加利福尼亚州IB-IIA期宫颈癌患者对国家综合癌症网络治疗指南的依从性差异及生存分析
该回顾性人群队列研究纳入1995年至2009年加利福尼亚州癌症登记处报告的6063例IB-IIA期浸润性宫颈癌患者,评估社会人口学和医院特征与指南依从性的关联及依从性与生存的关系。47%患者接受指南依从性治疗,非依从组宫颈癌死亡率13.3%高于依从组8.6%(效应量1.55,95%CI 1.34-1.80)。低社会经济地位、合并症评分≥1、低容量中心与较低指南依从性相关;黑人种族、医疗补助支付者和合并症评分≥1与宫颈癌死亡风险增加相关。
要点
- 47%的IB-IIA期宫颈癌患者接受了NCCN指南依从性治疗。
- 非依从组宫颈癌死亡率13.3%高于依从组8.6%(效应量1.55,95%CI 1.34-1.80)。
- 低社会经济地位和合并症评分≥1与接受非指南治疗相关。
核心结论
- 在早期宫颈癌患者中,NCCN指南非依从性治疗与宫颈癌特异性死亡率增加独立相关,黑人种族和医疗补助支付者状态亦相关。
- 非依从性在年龄较大、社会经济地位较低和在低容量中心接受治疗的患者中更普遍。
- 应注意提高指南依从性。
研究设计与样本
- 回顾性人群队列研究,纳入1995年1月1日至2009年12月31日加利福尼亚州癌症登记处报告的IB-IIA期浸润性宫颈癌患者,共6063例。
- 指南依从性定义为按年份和分期 appropriate 的手术、放疗和化疗。
- 使用多因素逻辑回归、Kaplan-Meier估计和Cox比例风险模型分析。
主要发现
- 47%患者接受NCCN指南依从性治疗,18.8%在高容量中心(每年20例或以上)治疗。
- 最低社会经济地位(调整OR 0.69,95%CI 0.57-0.84)、中低社会经济地位(调整OR 0.76,95%CI 0.64-0.92)和Charlson-Deyo合并症评分≥1(调整OR 0.78,95%CI 0.69-0.89)与接受非指南治疗相关。
- 低容量中心指南依从性治疗比例45.9%低于高容量中心50.9%(效应量0.90,95%CI 0.84-0.96)。
- 非依从组宫颈癌死亡比例13.3%高于依从组8.6%(效应量1.55,95%CI 1.34-1.80)。
- 黑人种族(调整HR 1.56,95%CI 1.08-2.27)、医疗补助支付者状态(调整HR 1.47,95%CI 1.15-1.87)和Charlson-Deyo合并症评分≥1(调整HR 2.07,95%CI 1.68-2.56)均与宫颈癌死亡风险增加相关。
临床怎么用
- 原文未据本研究结果给出具体临床推荐,仅指出应注意提高指南依从性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the association of sociodemographic and hospital characteristics with adherence to National Comprehensive Cancer Network treatment guidelines for stage IB-IIA cervical cancer and to analyze the relationship between adherent care and survival. METHODS: This is a retrospective population-based cohort study of patients with stage IB-IIA invasive cervical cancer reported to the California Cancer Registry from January 1, 1995, through December 31, 2009. Adherence to National Comprehensive Cancer Network guideline care was defined by year- and stage-appropriate surgical procedures, radiation, and chemotherapy. Multivariate logistic regression, Kaplan-Meier estimate, and Cox proportional hazard models were used to examine associations between patient, tumor, and treatment characteristics and National Comprehensive Cancer Network guideline adherence and cervical cancer-specific 5-year survival. RESULTS: A total of 6,063 patients were identified. Forty-seven percent received National Comprehensive Cancer Network guideline-adherent care, and 18.8% were treated in high-volume centers (20 or more patients/year). On multivariate analysis, lowest socioeconomic status (adjusted odds ratio [OR] 0.69, 95% CI 0.57-0.84), low-middle socioeconomic status (adjusted OR 0.76, 95% CI 0.64-0.92), and Charlson-Deyo comorbidity score 1 or higher (adjusted OR 0.78, 95% CI 0.69-0.89) were patient characteristics associated with receipt of nonguideline care. Receiving adherent care was less common in low-volume centers (45.9%) than in high-volume centers (50.9%) (effect size 0.90, 95% CI 0.84-0.96). Death from cervical cancer was more common in the nonadherent group (13.3%) than in the adherent group (8.6%) (effect size 1.55, 95% CI 1.34-1.80). Black race (adjusted hazard ratio 1.56, 95% CI 1.08-2.27), Medicaid payer status (adjusted hazard ratio 1.47, 95% CI 1.15-1.87), and Charlson-Deyo comorbidity score 1 or higher (adjusted hazard ratio 2.07, 95% CI 1.68-2.56) were all associated with increased risk of dying from cervical cancer. CONCLUSION: Among patients with early-stage cervical cancer, National Comprehensive Cancer Network guideline-nonadherent care was independently associated with increased cervical cancer-specific mortality along with black race and Medicaid payer status. Nonadherence was more prevalent in patients with older age, lower socioeconomic status, and receipt of care in low-volume centers. Attention should be paid to increase guideline adherence.
引用
- Pfaendler KS, Chang J, Ziogas A, et al. Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California. Obstet Gynecol. 2018. PMID: 29630020. doi:10.1097/AOG.0000000000002591
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。